Erratum: Polymorphism -433 C>T of the Osteopontin Gene is Associated with the Susceptibility to Develop Gliomas and their Prognosis in a Chinese Cohort

<b><i>Aim: </i></b>To investigate role of the Osteopontin (OPN) genetic polymorphisms in the susceptibility to gliomas and their prognosis. <b><i>Methods: </i></b>A total of 248 Chinese glioma patients and 281 age and sex matched healthy controls were recruited. The genetic polymorphisms at three loci, namely, -156 GG&gt;G, -443 C&gt;T and -66T&gt;G, were determined. The log-rank test and Kaplan- Meier analysis were introduced to assess the effect of OPN gene polymorphisms on patient survival. <b><i>Results: </i></b>We found that the genotype frequencies of OPN -443 C&gt;T polymorphism were significantly different between glioma patients and controls. Multivariable analyses showed a higher risk for gliomas in -443 CC genotype carriers compared to -443TT carriers (P&lt;0.001). In addition, we also found the OPN -443 C&gt;T polymorphism was closely related to the gliomas' tumor grade. The -443 C&gt;T polymorphism also affected the tumor OPN expression level, but not the serum OPN level. More importantly, the -443 C&gt;T polymorphism was significantly associated with the prognosis of these patients regardless of their treatment status. The patients with -443CC genotype had a poorer prognosis than those with -443TT and -443CT genotypes. In contrast, the -156 G&gt;GG and -66T&gt;G polymorphisms were not associated with risk, clinical characteristics, or prognosis of gliomas. <b><i>Conclusion: </i></b>This study suggests that the -443C&gt;T gene polymorphisms may be used as a molecular marker for glioma occurrence and clinical outcome in glioma patients. © 2014 S. Karger AG, Basel